Borrelia Infections
|
0.010 |
Biomarker
|
group |
BEFREE |
Our data demonstrate for the first time that ANO10 has a central role in innate immune defense against Borrelia infection.
|
25730773 |
2015 |
Malignant Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The excitement about Tmem16 proteins has been enhanced by the finding that Ano1 has been linked to cancer, mutations in Ano5 are linked to several forms of muscular dystrophy (LGMDL2 and MMD-3), mutations in Ano10 are linked to autosomal recessive spinocerebellar ataxia, and mutations in Ano6 are linked to Scott syndrome, a rare bleeding disorder.
|
21642943 |
2011 |
Cerebellar Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Cerebellar ataxia associated with ANO10 mutation (ARCA3) presents a disabling cerebellar syndrome.
|
28316589 |
2017 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Although TMEM16K is widely distributed and associated with the neurological disorder autosomal recessive spinocerebellar ataxia type 10 (SCAR10), its location in cells, function and structure are largely uncharacterised.
|
31477691 |
2019 |
Peripheral Neuropathy
|
0.010 |
GeneticVariation
|
group |
BEFREE |
An ANO10 mutation is responsible for ARCA that is mainly characterized by cerebellar atrophy and lack of peripheral neuropathy.
|
25089919 |
2014 |
Primary malignant neoplasm
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The excitement about Tmem16 proteins has been enhanced by the finding that Ano1 has been linked to cancer, mutations in Ano5 are linked to several forms of muscular dystrophy (LGMDL2 and MMD-3), mutations in Ano10 are linked to autosomal recessive spinocerebellar ataxia, and mutations in Ano6 are linked to Scott syndrome, a rare bleeding disorder.
|
21642943 |
2011 |
Peripheral Nervous System Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
An ANO10 mutation is responsible for ARCA that is mainly characterized by cerebellar atrophy and lack of peripheral neuropathy.
|
25089919 |
2014 |
Diplopia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscular fasciculation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hyperreflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Polysomnography
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
|
23251661 |
2012 |
Cerebellar Dysmetria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Action Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Slurred speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ankle clonus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypermetric saccades
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia, Truncal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Downbeat nystagmus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia, Appendicular
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysmetric saccades
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Saccadic smooth pursuit
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Progressive gait ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tortuosity of conjunctival vessels
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|